source
- Tirabrutinib and CAR T-cell therapy show promise for relapsed/refractory primary CNS lymphomaExperts highlighted emerging data on tirabrutinib and CAR T-cell therapy as potential new options for patients with relapsed or refractory primary central nervous system lymphoma. CAR T-cell thera…
- Experts discuss combination and sequencing approaches for radiopharmaceuticals in advanced prostate cancerDr. Pedro Barata and Dr. Johann De Bono review the current questions surrounding how best to combine and sequence radiopharmaceutical therapies for patients with metastatic castration‑resistant pro…